Click Title for complete article or
click Summary for overview of each
article.
[OHM]-2009
Salary Survey Results: Occupational health salary
increases "minimal" but role continues to cross
boundaries
From AHC Newsletters -
Jan 14,
2010
2009 Salary
Survey Results. Occupational health salary
increases "minimal" but role continues to cross
boundaries. Take a risk on new skill sets. During
a meeting with an employee about a worker's
compensation issue, you encourage him to take
advantage of a discounted YMCA membership. While
doing an environmental assessment for toxic
chemicals, you teach workers about Material Safety
Data Sheets.
[ Summary
]
HHS
Secretary Kathleen Sebelius and Hunter College
Host Event to Encourage Young People to Get the
H1N1 Vaccine During National Influenza Vaccination
Week
From
PharmaLive News Archive - Jan 13, 2010
WASHINGTON--(BUSINESS WIRE)--Jan 14,
2010 - The U.S. Department of Health and Human
Services (HHS) and its Centers for Disease Control
and Prevention (CDC) will hold an H1N1 vaccination
roundtable discussion with Hunter College students
and faculty in New York City on Thursday, January
14, 2010.
[ Summary
]
| Genomics and
Biotechnology |
| Click Title for complete article or
click Summary for overview of each
article.
Tesla
Bio Workbench Enables Scientists to Achieve New
Breakthroughs in Biosciences
From Market Wire - Jan 14, 2010
01/14/10 -- NVIDIA today announced
the Tesla Bio Workbench, which enables scientists
to push the boundaries of biological research by
turning a standard PC into a "computational
laboratory" capable of running complex bioscience
codes in fields such as drug discovery and DNA
sequencing more than 10-20 times faster through
the use of NVIDIA® Tesla GPUs.
[ Summary
]
UK
Stem Cell Foundation & MS Society Stem Cell
Research Collaboration
From PR Newswire Europe & UK
Disclose - Jan 14,
2010
Stem cell
research in multiple sclerosis has been given a
much-needed shot in the arm thanks to a
partnership between the UK's largest charity
supporting people affected by the condition and
the UK's only charity dedicated to supporting stem
cell research.
[ Summary
]
Kenta
Biotech Announces Collaboration with Rentschler
Biotechnologie for Antibody Development Against
Hospital-Acquired Infections
From PharmaLive News Archive -
Jan 13,
2010
BERNE,
Switzerland--(BUSINESS WIRE)--Jan 14, 2010 - Kenta
Biotech today announced an agreement with
Rentschler Biotechnologie for the development of a
fully human monoclonal antibody against
methicillin-resistant Staphylococcus aureus
(MRSA).
[ Summary
]
STELARA(TM)
Shows Greater Efficacy Than Etanercept for
Treatment of Moderate to Severe Plaque Psoriasis:
Phase 3 Comparator Study Published in The New
England Journal of Medicine
From PR Newswire US -
Jan 14,
2010
HORSHAM, Pa.,
Jan. 14Findings from an international, Phase 3
clinical study comparing the efficacy and safety
of STELARA with etanercept in the treatment of
moderate to severe plaque psoriasis appear today
in The New England Journal of Medicine. Psoriasis
is an inflammatory disorder characterized by
raised, inflamed, red lesions, or plaques, which
can cause physical pain.
[ Summary
]
Affimed
Therapeutics AG completes move into drug
development
From Hugin (English) -
Jan 14,
2010
Affimed
Therapeutics AG / Affimed Therapeutics AG
completes move into drug development processed and
transmitted by Hugin AS. Spinout AbCheck s.r.o. to
focus on antibody discovery.
[ Summary
]
Pfizer
exec: Wyeth has added value to drug pipeline [The
Day, New London, Conn.]
From Day, The (New London, CT) -
Jan 13,
2010
Jan.
13--Martin Mackay, president of Pfizer Inc.'s
PharmaTherapeutics research division, told a
healthcare conference Tuesday in San Francisco
that the company received "great additions to the
pipeline" when it acquired Wyeth Pharmaceuticals
late last year. Speaking at the annual J.P. Morgan
Healthcare Conference, Mackay said Pfizer expects
big things from Wyeth's Prevnar 13 pneumococcal
vaccine.
[ Summary
]
| FDA: New Treatments and
Technology |
| Click Title for complete article or
click Summary for overview of each
article.
FDA
Gives TCA Cellular Therapy Green Light to Proceed
with First ALS Adult Stem Cell Trial Using
Patient's Own Stem Cells
From PharmaLive News Archive -
Jan 12,
2010
COVINGTON,
La.--(BUSINESS WIRE)--Jan 13, 2010 - TCA Cellular
Therapy, LLC (TCA-CT) announced today that the
U.S. Food and Drug Administration (FDA) has
approved its adult stem cell protocol to conduct
Phase I clinical trials to treat Amyotrophic
Lateral Sclerosis (ALS or Lou Gehrig's
disease).
[ Summary
]
CareFusion
gains FDA nod to resume making, marketing Alaris
SE pump
From
M2 Europharma - Jan 13,
2010
13 January
2010 - US medical technology company CareFusion
Corporation said on Monday that the US Food and
Drug Administration has granted the company
permission to resume manufacturing and marketing
of the Alaris SE line of infusion pumps.
CareFusion, formerly the Clinical and Medical
Products division of Cardinal Health, has been
operating under a consent decree with the FDA
since February 2007.
[ Summary
]
Octapharma
Receives Orphan Drug Exclusivity Approval for
wilate - A Replacement Therapy Developed
Specifically for von Willebrand
Disease
From
PharmaLive News Archive - Jan 12, 2010
LACHEN, Switzerland, Jan. 13
/PRNewswire/ -- Octapharma AG, one of the largest
manufacturers of plasma products in the world,
today announced that it has received orphan drug
exclusivity approval for wilate® from the U.S.
Food and Drug Administration (FDA). The approval
was granted for the use of wilate® for the
treatment of spontaneous or trauma-induced
bleeding episodes in patients with severe von
Willebrand disease (VWD) as well as in patients
with mild or moderate VWD in whom the use of
desmopressin is known or suspected to be
ineffective or contraindicated.
[ Summary
]
FDA
committee recommends approval of Actelion's
Zavesca for Niemann-Pick type C
disease
From
M2 Europharma - Jan 13,
2010
13 January
2010 - Swiss biopharmaceutical company Actelion
Ltd said yesterday that the US Food and Drug
Administration's Endocrinologic and Metabolic
Drugs Advisory Committee voted to recommend
approval of the supplemental New Drug Application
of Zavesca for the treatment of Niemann-Pick type
C disease.
[ Summary
]
FDA
approves Wockhardt's antibacterial
Levofloxacin
From M2 Europharma -
Jan 13,
2010
13 January
2010 - India-based pharmaceutical and
biotechnology major Wockhardt Ltd said today that
the US Food and Drug Administration approved for
marketing the 250 mg, 500 mg and 750 mg tablets of
Levofloxacin for treatment of bacterial
infections. Levofloxacin is the generic name for
the brand Levaquin, marketed in the USA by Ortho
Mcneil.
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
Continued
Reduction in State Medicaid Reimbursement Forces
Walgreens To Stop Filling Medicaid Prescriptions
at 64 Washington Pharmacies as of Feb.
15
From
PharmaLive News Archive - Jan 13, 2010
DEERFIELD, Ill.--(BUSINESS
WIRE)--Jan 14, 2010 - As a result of continued
reduction in reimbursement under the State of
Washington Medicaid program, Walgreens today
announced it will withdraw 64 of its pharmacies
from the state's Medicaid program as of Feb. 15.
These pharmacies represent 75 percent of the
company's total Medicaid business in the state.
Walgreens operates 121 pharmacies throughout
Washington.
[ Summary
]
U.S.
HealthWorks in Spokane is Offering $15 H1N1
Vaccinations for Both Walk-Ins and
On-Site
From
PR Web - Jan 13,
2010
Get Vaccinated
Against a Second Wave of H1N1 Flu for Only $15 and
No Waiting in Long Lines -- National Influenza
Awareness Week Jan. 10-16, 2010.
[ Summary
]
Hy-Vee
Pharmacy Solutions to Offer Specialty Pharmacy
Services
From PR Newswire US -
Jan 13,
2010
WEST DES
MOINES, Iowa, Jan. 13A leading retail pharmacy
chain has teamed with one of the nation's largest
privately-owned specialty pharmacies to form a new
company that will provide more accessible services
for patients dealing with complex and chronic
health conditions.
[ Summary
]
AstraZeneca
Offers Online Enrollment and Additional
Improvements to Patient Assistance
Program
From
PR Newswire US - Jan
13, 2010
WILMINGTON, Del., Jan.
13AstraZeneca announced today that enrollment and
re-enrollment for two of its prescription savings
programs is available online for the first time at
www.azandme.com. In addition, online self-service
options are available for both programs, which
enable health care providers, advocates and
patients to order and monitor the shipping of
refills and check the status of
thei...
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
Abbott
receives CE Mark for ovarian cancer
test
From M2
Europharma - Jan 14,
2010
14 January
2010 - US-based health care company Abbott
Laboratories Inc said today it received CE Mark
certification for its ARCHITECT human epididymis
protein 4 test expected to help in the assessment
of epithelial ovarian cancer.
[ Summary
]
Bionovo
Announces Publication of Positive Results From the
Phase 1B Clinical Trial of Bezielle (BZL101) for
Metastatic Breast Cancer
From PR Newswire US -
Jan 14,
2010
EMERYVILLE,
Calif., Jan. 14Bionovo, Inc. announced today the
publication of their results from its phase 1B
clinical trial of Bezielle for metastatic breast
cancer. The purpose of the phase 1B clinical trial
was to identify the maximum tolerated dose of
Bezielle and to determine the safety and
feasibility of the company's novel, oral,
anticancer treatment.
[ Summary
]
Dotmatics
Licenses Its Suite of Tools to the Institute of
Cancer Research
From Market Wire - Jan 14, 2010
01/14/10 -- Dotmatics is pleased to
announce that it has licensed its enterprise
query, reporting, registration and data management
tools to The Institute of Cancer
Research.
[ Summary
]
Nektar
reports promising results for NKTR-102 in ovarian
cancer
From
M2 Europharma - Jan 14,
2010
14 January
2010 - US biopharmaceutical company Nektar
Therapeutics reported on Tuesday preliminary
results from the first stage of a two-stage Phase
II study evaluating NKTR-102 in women with
platinum-resistant ovarian cancer.
[ Summary
]
CytRx
to Conduct Phase 2 Clinical Trial with Bafetinib
in B-cell Chronic Lymphocytic
Leukemia
From PharmaLive News Archive -
Jan 12,
2010
LOS
ANGELES--(BUSINESS WIRE)--Jan 13, 2010 - CytRx
Corporation, a biopharmaceutical company
specializing in oncology, today announced plans to
initiate a Phase 2 proof-of-concept clinical trial
to evaluate the efficacy and safety of bafetinib
(formerly known as INNO-406) in patients with
high-risk B-cell chronic lymphocytic leukemia
(B-CLL).
[ Summary
]
NAMCP's Medical
Directors Resource Centers
The
purpose of NAMCP's Medical Directors Resource
Centers is to provide Medical Directors with
access to disease specific information and
resources and to improve patient
outcomes.
Accessing NAMCP's Medical
Directors Resource Centers will allow you
to:
Use screening tools to diagnose
Access treatment and best practice guidelines
Improve patient adherence and compliance
Improve patient outcomes
Better manage patients
Review cost of treatment versus overall
economic burden
Provide resources for your network physicians
Provide resources for patients
CLICK
HERE to access the Obesity Resource
Center
CLICK
HERE to access the Sleep Resource
Center
CLICK
HERE to access the Diabetes Resource
Center
Exclusive
Medical Director's Website
Click
here to sign up for free access to
the exclusive Medical Director's Website. Features
include a discussion forum, career information,
and consolidated clinical links to important
managed care websites. You must be a Medical
Director to gain access to the website. Keep
current on all of the issues surrounding Medical
Directors in today's market. Access is free
for all Medical Directors. Please contact Jeremy
Williams at jwilliams@namcp.org
for more information! For those of you who are
not Medical Directors, please forward the link or
eNews to any Medical Directors in your company
that may be interested in the website.
CLICK THE FOLLOWING TITLES
TO PARTICIPATE IN THE ONLINE
CME/CEU
Prevention,
Diagnosis & Treatment of COPD
-
Supported by Boehringer Ingelheim/Pfizer Inc.
The
Relationship and Impact of Diabetes and
Cardiovascular Disease
- Supported
by Daiichi-Sankyo, Merck and sanofi aventis
Current
Concepts in Managing Dyslipidemia
-
Supported by AstraZeneca
Clinical
and Financial Implications of Wound Care
Management Across the Care
Continuum
- Supported by Kinetic
Concepts, Inc. (KCI)
Schizophrenia:
Improving Outcomes While Managing
Care
- Supported by Bristol-Myers
Squibb and Pfizer, Inc.
The
Physical and Fiscal Impact of Sleep
Disorders
- Supported by Cephalon
and sanofi-aventis
The
Management and Treatment of Parkinson's
Disease
- Supported by Teva
Neuroscience
MS:
The New Treatment Paradigm: A Pathway to Success
for Improved Patient Outcomes
-
Supported by Bayer Healthcare, Inc.
How
to Improve Outcomes in a Patient Population of
Asthmatics
- Supported by
AstraZeneca
Stroke:
Primary and Secondary Prevention
-
Supported by Bristol-Myers Squibb
Economic
Value of the Prevention and Treatment of Diabetic
Ulcers
- Supported by KCI
Management
of the Liver Transplant Patient
-
Supported by Astellas
The
Relationship & Impact of Osteoporosis &
Breast Cancer in Post Menopausal
Women
- Supported by Eli Lilly
Implementation
of Comprehensive RSV Management Plan to Improve
Patient, Provider and Plan
Outcomes
- Supported by MedImmune,
Inc.
Pain
Management
- Supported by Alpharma
Pharmaceuticals
Obesity
Management
- Supported by Allergan,
Inc.
Health
Economic Implications of Wound Care and Limb
Preservation
- Supported by KCI,
Inc.
| Journal of Managed Care
Medicine |
Your Logo
Here |
Journal of Managed Care
Medicine Vol 12, Issue 4 Table of
Contents
 Below
you will find the table of contents for the
current issue of JMCM. You can click
here to visit our main journal page, or
click on each individual article below to visit
their article page and then download the
PDF!
Click
the titles below to visit the indvidual article
download page.
The
Financial Implications of New Episodes of MDD for
Treatment Resistant Versus Stable Depressed
Individuals
C. Daniel
Mullins, PhD, Brian Seal, PhD and Lisa Blatt,
MA
Behavioral
Health Update
Mark
Rosenberg, MD, PHD
Hospital
Contracting Trends
Eric
Faulkner, MPH, Josephine Mauskopf, PhD and Jay
Bae, PhD
The
Management of Metabolic Health in the
Workplace
William Bunn,
III, MD, JD, MPH, Joseph Leutzinger, PhD, Richard
Nevins, MD, John Seibel, MD, FACP, MACE, and Sean
Sullivan, JD
The
Relationship Between Rheumatoid Arthritis and
Heart Failure
Geneva
Briggs, PharmD
Clinical
Utility or Impossibility? Addressing the Molecular
Diagnostics Health Technology Assessment and
Reimbursement
Conundrum
Eric Faulkner,
MPH
Complete
12.4
Issue
| Press
Release |
Your Logo
Here |
America Needs Business
Numbers
In December, the U.S.
Census Bureau mailed Economic Census forms to more
than 4 million businesses - to all large and
medium businesses and many small businesses. If
you received a form, the law (Title 13, U.S. Code)
requires that you complete and return it. The due
date is February 12, less than a month
away.
Economic indicators we use all the
time -- like Gross Domestic Product, monthly
retail sales, and the producer price index -- all
depend on the Economic Census for continued
accuracy. The data are also used by businesses
large and small, and by this association. Ben
Bernanke says this census is "indispensable to
understanding America's economy."
If you
need more information or help completing the form,
see the Census Bureau's business help site at www.census.gov/econhelp
or call 1-800-233-6136.
America needs your
numbers.
| Job
Postings |
Your Logo
Here |
Visit NAMCP's Career
Center!
To find a job or fill a position, visit
http://careers.namcp.org.
You can also click on the links following each
individual job below to be taken to their new page
on our career center.
Job
seekers and employers have discovered the
advantages of searching online for the best jobs
and for qualified candidates to fill them. But,
the mass-market approach of the mega job boards
may not be your best avenue.
NAMCP's Career
Center gives employers and job seeking managed
care professionals a better way to find one
another and make that perfect career
fit.
For Job Seekers: Post your
resume; Search job listings; Set up Search Agents;
and have new postings sent to you via
email.
For Employers: Post your
jobs; Target a focused audience of candidates;
Search resumes; Track applications; Promote your
company online.
If you
would like to post a job on Genomics Biotech
eNews, please contact Sloane Reed at
sreed@namcp.org or 804-527-1905 for
rate information.
In
accordance with our mission, to enhance the
ability of our members to succeed in their
careers, we are pleased to offer comprehensive
career consultation and national executive
placement services. As a benefit of membership for
our client organizations, i.e., anyone seeking to
hire experienced staff, we offer exceptional
executive search services and at a discounted
rate. We have access to the highest caliber of
managed care talent and have a distinguished track
record in placing physician and nurse executives
as well as executive operations personnel (CEO,
COO, CFO, Director of Managed Care, Network
Development, etc.)
If you have an available
position or have an interest in our placement
service, please contact David Mara at
(804)527-1905 or e-mail at dmara@namcp.org.
For a more detailed job description for any of
the jobs listed below, please contact Dave Mara at
804.527.1905 or email him at dmara@namcp.org
You
can also CLICK HERE to visit our Job
Placement and Career Counseling page to view the
full descriptions for all of these jobs and
more!
Medical Director, Clinical Research, North
America
New Jersey
Job
Summary
The Medical Director-Clinical
Research, North America reports to the Executive
Medical Director. The incumbent is responsible for
developing and implementing product development
strategies initially in the Gastroenterology
therapeutic area but later may involve in other
therapeutic areas as derived from the company's
pipeline and/or in licensed development products.
While the individual is expected to manage the
conduct of clinical trials in the US, there is a
strong component involving participation in global
project development teams. The Medical Director
will be expected to undertake all the duties
normally associated with the execution of clinical
trials and to establish clinical advisory boards
in the areas of product development.
For
more information, please call David Mara at
804.527.1905. To review additional positions go to
www.nexushc.com
Medical Director
New
Jersey
Job Summary
The
Medical Director reports to the Vice President of
Infertility and Orthopedics. The incumbent is
responsible for developing and implementing
product development strategies initially in the
OBGYN therapeutic areas but later may involve in
other therapeutic area; as derived from the
company pipeline and/or in licensed development
products. While the individual is expected to
manage the conduct of clinical trials in the US
there is a strong component involving
participation in global project development teams
managed from the company's International Center in
Copenhagen. The Medical Director will be expected
to undertake all the duties normally associated
with the execution of clinical trials and to
establish clinical advisory boards in the areas of
product development.
For more information,
please call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Medical Director, Clinical Research, North
America
New Jersey
Job
Summary
The Medical Director-Clinical
Research, North America reports to the Executive
Medical Director. The incumbent is responsible for
developing and implementing product development
strategies initially in the Urology therapeutic
area but later may involve in other therapeutic
area as derived from the company's pipeline and/or
in licensed development products. While the
individual is expected to manage the conduct of
clinical trials in the US there is a strong
component involving participation in global
project development teams. The Medical Director
will be expected to undertake all the duties
normally associated with the execution of clinical
trials and to establish clinical advisory boards
in the areas of product development.
For
more information, please call David Mara at
804.527.1905. To review additional positions go to
www.nexushc.com
Chief Medical Officer
San Francisco,
CA
Job Summary
The Chief
Medical Officer (CMO) for the Healthcare Services
organization will be integral in the realization
of the health plan's mission, by providing
leadership and direction for health management and
clinical quality improvement strategies, providing
greater value to its members through pharmacy and
medical management, and optimally functioning
management systems.
For more information,
please call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Associate Medical Director
Nashville, TN
Job Summary
Working with the
Chief Medical Director, oversees medical care for
the health plan's products and services and
oversees the health care needs of the membership.
Serves as a medical manager and policy advisor to
the company and health plan Chief Medical
Director. Is accountable for and provides
professional leadership and direction to the
utilization/cost management and clinical quality
management functions. Works collaboratively with
other plan functions that interface with medical
management such as provider relations, member
services, benefits and claims management, etc.
Assists (as determined by the plan Chief Medical
Director) in short and long range program
planning, total quality management (quality
improvement) and external
relationships.
For more information, please
call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Chief Medical Officer
Nashville, TN
Overview
Oversees all
medical care for the health plan's products and
services. Oversees the health care needs of the
membership. Serves as the principal medical
manager and policy advisor to the company and
health plan CEO or COO. Is accountable for and
provides professional leadership and direction to
the utilization/cost management and clinical
quality management functions. Works
collaboratively with other plan functions that
interface with medical management such as provider
relations, member services, benefits and claims
management, etc.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
MEDICARE HMO EXPANDING - NEW MARKET
OPPORTUNITY
Medical Director
Mobile,
AL
Job Summary
This position
is responsible for the administration of all
medical services for the corporation. It is
responsible for the coordination of medical
policy, peer review, quality management,
legal/medical issues, and the effectiveness of the
Medical Management Program.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
Medical Director
Virtual
Job
Summary
A leading healthcare technology and
service company that provides solutions for
healthcare organizations, has a unique experience
base, extensive healthcare information and
advantaged technology applications which create
value through reduced medical costs, reduced
administrative costs and improved care
coordination is seeking a Medical Director to
support a growing client base and maintain their
competitive advantage in the depth of clinical
logic.
The Medical Director is instrumental
within the company in directing the Logic
Committee (Medical Policy Committee) which is
composed of medical directors, coding analysts,
provider relations, contracting people, etc. At
the Logic Committee, the company goes through
their Global Medical Policy document as it relates
to claims coding and then subsequently reviews
individual edits that have potential value for the
client.
Please direct all inquires to Dave
Mara at 804-527-1905.
Manager, Provider Relations and
Contracting
Austin, TX; Ft. Lauderdale; Orlando
and Tampa, FL
Summary
This
behaviorial health company is a multi-line managed
care organization that provides Medicaid-related
programs to organizations and individuals through
government subsidized programs. We have an
excellent opportunity for a Manager of Provider
Relations and Contracting. This position will
implement development activities for the
recruitment, contracting and retention of
providers. Negotiate contracts and develop
strategies and methodologies for specific network
development initiatives.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
| | |
| Genomics Biotech Institute eNews
for January 14, 2010
|
Produced by NAMCP & Genomics Biotech
Institute
4435 Waterfront Drive, Suite
101
Glen Allen, VA 23060
Telephone:
804-527-1905
Fax: 804-747-5316 |
Click "Opt-out of this
newsletter" at the top of the newsletter or
contact Jeremy Williams at jwilliams@namcp.org
or 804-527-1905 to be taken off the
list | | | | |
|
| NAMCP Medical Directors Resource
Centers |
|
The purpose of NAMCP's Medical Directors
Resource Centers is to provide Medical Directors
with access to disease specific information and
resources and to improve patient
outcomes.
Accessing NAMCP's Medical
Directors Resource Centers will allow you
to:
Use screening tools to diagnose
Access treatment and best practice guidelines
Improve patient adherence and compliance
Improve patient outcomes
Better manage patients
Review cost of treatment versus overall
economic burden
Provide resources for your network physicians
Provide resources for patients
CLICK
HERE to access the Obesity Resource
Center
CLICK
HERE to access the Sleep Resource
Center
CLICK
HERE to access the Diabetes Resource
Center
| | |
| NAMCP Behavioral Health Resource
Center |
|
Preventative Behavioral Health Treatment:
Stress and Medical Illness
New studies
are proving how inextricably linked stress is to
physical health. Stress may be affecting your
patient?s health in more ways than you think.
Discover the latest links between stress and
serious illness. For more info please click
here.
If you are interested in the
NAMCP Behavioral Health Resource Center, please
contact Katie Eads at 804-527-1905 or keads@namcp.org.
| | |
| JOURNAL OF MANAGED CARE MEDICINE
(JMCM) |
|
Vol. 12, No. 4 has been
released! Scroll below to the Journal Section
below for downloadable
articles! | | |
| EMPLOYMENT
OPPORTUNITIES |
|
Call Dave Mara at (804) 527-1905 for
information on any of the following job
openings.
Medical Director, Clinical Research, North
America, New Jersey
Medical Director, New Jersey
Chief Medical Officer, San Francisco, CA
Medical Director, Mobile, AL
Medical Director, Virtual
Chief Medical Officer, Nashville, TN
Manager, Provider Relations and Contracting,
Austin, TX; Ft. Lauderdale, Orlando and Tampa,
FL
VP of Health Services, Birmingham, AL, Miami,
FL and New Orleans, LA
VP, Health Care Management Services, Multiple
Locations
Senior Medical Director, Houston,
TX
For more information or for more
detailed job descriptions, please contact Dave
Mara at 804.527.1905 or email your resume to dmara@namcp.org
| | |
|
